Photos of Deborah Mukherji, Enrique Grande and Patrizia Giannatempo
Jul 10, 2024, 08:31
ASCO – Why biomarkers are needed to optimize outcomes and avoid toxicities
ASCO shared on X:
“Though novel therapies have improved survival in patients with mUC, many will still develop resistance. For ASCO Daily News, Enrique Grande, Patrizia Giannatempo and Deborah Mukherji discuss why biomarkers are needed to optimize outcomes and avoid toxicities.”
Read further.
Source: ASCO/X